Repositioning Immunotherapy in VetArans With Lung Cancer
Status:
RECRUITING
Trial end date:
2030-03-31
Target enrollment:
Participant gender:
Summary
This study is a multicenter Phase II single arm trial to assess the safety and efficacy of chemotherapy and immunotherapy followed by radiotherapy in patients with unresectable Stage III NSCLC.